Core Strengths in Biologics Development and ​GMP Manufacturing

​Protein, Vaccine, and Antibody Techniques and Manufacturing Process

• Strain screening, cloning, expression to purification
• Scale-up, optimization, and technology transfer
• Using state-of-the-art production platform for cost saving and efficient manufacturing
• Mammalian Cell:  Serum free, reduced immune response, protein modification
• ​​Microbial: Improved filtration process for large scale, glycosylation, endotoxin free products, codon optimization​​

cGMP Manufacturing Experience 

• Quality system implementation​
• Clean room design
• Equipment qualification
• Process validation
• Cleaning validation

Taron’s advantages over current CMOs

​​Regulatory Certification ​

• ​We obtain GMP manufacturing license that satisfy PIC/S and FDA guidelines.  This positions Taron Solutions as a global competitor to existing CMOs in Asia.  

​Strategic partnerships

• Taron Solutions is positioned to be the preferred company for Hong Kong for the cross strait 4 territories initiative between China, Hong Kong, Taiwan, and Macau.
• We have partners with universities in the US and Hong Kong, as well as other regional companies.

​Strengths

• We can enhance production reliability for manufacturing biologics as well as reduce cost to tackle challenges within the industry.
• Our expertise in toxicology, clinical and commercial supplies are valuable for biotechnology companies that we have established long term partnership with.

​Hong Kong Location

• Excellent IP protection for our clients.
• Taron Solutions are part of the One-Belt-One Road initiative enabling companies to enter the US market.
• Serves as a gateway to help companies in Hong Kong, China, Taiwan, and other regional countries manufacture products that meet FDA standards for clinical trials.

Track Record

• World class expertise to help clients optimize and manufacture biopharmaceuticals.
• Network of technical and regulatory expertise through our partners in the US.

Pricing

• Pricing is competitive compared to other larger CMOs in US and Europe due to the lower operational cost in Asia.

Current Strategic Partners

---

Taron Solutions is supporting joint collaboration on department projects.

---

​ Tufts University School of Medicine 

Taron Solutions enters agreement to study molecular signalling network involved in complex human disease.